Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

21.0%

22 terminated/withdrawn out of 105 trials

Success Rate

77.6%

-9.1% vs industry average

Late-Stage Pipeline

45%

47 trials in Phase 3/4

Results Transparency

59%

45 of 76 completed trials have results

Key Signals

5 recruiting45 with results18 terminated4 withdrawn

Enrollment reporting

Analytics

Phase 3

43(43.9%)

Phase 1

32(32.7%)

Phase 2

15(15.3%)

Phase 4

4(4.1%)

N/A

2(2.0%)

Phase 2/3

2(2.0%)

98Total

Phase 3(43)

Phase 1(32)

Phase 2(15)

Phase 4(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (105)

Showing 20 of 105 trials

NCT07807644Phase 2Not Yet Recruiting

A Clinical Trial of GRT7040 in Adults With Acute Pain Following Bunionectomy

Role: lead

NCT07347548Phase 1Completed

A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

Role: lead

NCT07479745Phase 1Completed

Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

Role: lead

NCT07602387Not ApplicableRecruiting

Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%.

Role: collaborator

NCT03794388Phase 3Completed

Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery

Role: collaborator

NCT05840562Phase 3Recruiting

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

Role: collaborator

NCT05248386Phase 3Completed

Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

Role: lead

NCT05449132Phase 3Completed

Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee

Role: lead

NCT05377489Phase 3Completed

Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee

Role: lead

NCT07289776Phase 1Recruiting

A First-in-human Trial of GRT7041 in Healthy Participants

Role: lead

NCT07317063Phase 1Completed

A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants

Role: lead

NCT03910738Phase 2Recruiting

TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

Role: collaborator

NCT03834922Completed

Providing Standardized Consented PROMs (Patient Reported Outcome Measures) for Improving Pain Treatment

Role: collaborator

NCT06444919Phase 4Recruiting

Capsaicin in Digital Osteoarthritis Versus Control

Role: collaborator

NCT03745404Phase 3Completed

A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)

Role: lead

NCT03765697Phase 3Completed

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

Role: lead

NCT04001244Completed

Translational Research in Pelvic Pain

Role: collaborator

NCT04835779Unknown

Biometric and Biological Data for Diagnosis and Therapy of Pain Patients

Role: collaborator

NCT02880722Completed

Experience Sampling Method for Symptom Assessment in Irritable Bowel Syndrome

Role: collaborator

NCT03814993Completed

taPentadol cLinical prAcTice IN belgiUM

Role: collaborator